Showing results (571-580 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|August 13, 2005
Phase I and pharmacokinetic study of docetaxel, irinotecan, and celecoxib in patients with advanced non-small cell lung cancerAthanassios Argiris, Victoria Kut, Lynn Luong, et al.
Investigational New Drugs|July 22, 2005
A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancerBasil F El-Rayes, Mark M Zalupski, Anthony F Shields, et al.
Investigational New Drugs|January 2, 2007
Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancersSanjay Goel, Kavita Desai, Sirisha Karri, et al.
Investigational New Drugs|March 17, 2007
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancersT Ciuleanu, M Diculescu, N M Hoepffner, et al.
Investigational New Drugs|March 21, 2007
Docetaxel-ifosfamide combination in patients with HER2-non-overexpressing advanced breast cancer failing prior anthracyclinesChristos Kosmas, Nicolas Tsavaris, Nikolaos Malamos, et al.
Investigational New Drugs|March 21, 2007
Pro-apoptotic activity of imidazole derivatives mediated by up-regulation of Bax and activation of CAD in Ehrlich Ascites Tumor cellsC Anil Kumar, Shankar Jayarama, Basappa, et al.
Investigational New Drugs|March 9, 2007
Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactionsNancy U Lin, Leroy M Parker, Steven E Come, et al.
Investigational New Drugs|March 14, 2007
Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) studyKoji Takeda, Nobuhide Takifuji, Shunichi Negoro, et al.
Investigational New Drugs|December 6, 2006
Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumorsI E L M Kuppens, P O Witteveen, M Schot, et al.
Investigational New Drugs|December 6, 2006
A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumoursTara Baetz, Elizabeth Eisenhauer, Lillian Siu, et al.
Pageof 372